🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

12 results for “Oric Pharmaceuticals” Clear

  1. Placebo, DRY EXTRACT FROM CHASTE TREE FRUITS (7-11:1), EXTRACTION SOLVENT: ETHANOL 70% (V/V)

    Oric Pharmaceuticals

    Primary Dysmenorrhea

    phase 3 small molecule active

    1 trial

  2. ORIC-114

    Oric Pharmaceuticals

    Solid Tumors

    phase 2 small molecule active

    1 trial

  3. ORIC-114

    Oric Pharmaceuticals

    Solid Tumors

    phase 2 small molecule active

    1 trial

  4. ORIC-101

    Oric Pharmaceuticals

    Solid Tumor

    phase 1 small molecule terminated

    1 trial

  5. ORIC-101

    Oric Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials

  6. ORIC-101

    Oric Pharmaceuticals

    Prostatic Neoplasms

    phase 1 small molecule terminated

    1 trial

  7. ORIC-114

    Oric Pharmaceuticals

    Food Effect in Healthy Participants

    phase 1 small molecule completed

    1 trial

  8. ORIC-114 Dose 1 + amivantamab

    Oric Pharmaceuticals

    Solid Tumors

    phase 1 small molecule active

    1 trial

  9. ORIC-533

    Oric Pharmaceuticals

    Relapsed or Refractory Multiple Myeloma

    phase 1 small molecule completed

    1 trial

  10. ORIC-944

    Oric Pharmaceuticals

    Metastatic Prostate Cancer

    phase 1 small molecule active

    1 trial

  11. Ph 1 Study of ORIC-944 in Patients with Metastatic Prostate Cancer.

    Oric Pharmaceuticals

    Prostate cancer

    phase 1 other active

    1 trial

  12. Pharmacokinetics, pharmacodynamics, safety, and tolerability of an acetonic milk thistle extract, standardized to silymarin, in subjects with MASLD

    Oric Pharmaceuticals

    chronic liver disease

    phase 1 other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources